Kronox Lab Sciences Limited (KRONOX)
Revised Submissoin of Annual Report for the year 2025-26
Press Release - FY26
- Revenue 101.22 Cr +1% y-y; PAT 27.66 Cr +8.6% y-y
- Total income rose 3.6% to Rs. 106.41 Cr; net profit increased 8.61%
- Dividend recommended at Rs. 0.50/share (5%) for FY26
- Capex underway for Unit IV at Dahej; production to start in 2 years
- Strong balance sheet with net worth Rs. 116.13 Cr and current ratio 7.6
- CSR spend Rs. 57.6 Lakhs on education, heritage, animal welfare
- Board stable; no change in directors; reappointment of MD and WTDs
- No material regulatory or legal issues; clean audit report
- Foreign exchange earnings increased to Rs. 30.81 Cr
- Management confident on growth despite geopolitical challenges
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 KRONOX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add KRONOX to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Kronox Lab Sciences Limited
Important.
The summary above is generated automatically from Kronox Lab Sciences Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.